Product
SARS-CoV-2 inactivated vaccine
2 clinical trials
2 indications
Indication
COVID-19Indication
VaccinesClinical trial
A Phase I, Observer-Blind, Randomized, Controlled Study of the Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine (Adjuvanted With Alum+CpG 1018) in Healthy Populations Aged 18 Years and Above in IndonesiaStatus: Completed, Estimated PCD: 2022-08-02
Clinical trial
Multicenter, Phase 3, Randomized Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against SARS-CoV-2 Infection in Adults.Status: Completed, Estimated PCD: 2022-08-01